#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia recurrent Glioblastoma Neuronal ceroid lipofuscinosis HER2 gene amplification Haemophilia B with anti factor IX Systemic scleroderma Phenylketonuria Basal cell naevus syndrome Anti-neutrophil cytoplasmic antibody positive vasculitis Necrotising enterocolitis neonatal Chronic hepatitis B Hereditary ataxia Epilepsy Non-small cell lung cancer recurrent Arterial disorder More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia – Life with Disease Leiomyosarcoma Waldenstrom’s macroglobulinaemia – Diagnostics Erdheim-Chester disease – Trials in Disease Inclusion body myositis Aicardi-Goutieres syndrome – Treatment Glomerulonephritis membranous – Diagnostics Niemann-Pick disease – Life with Disease Leukoencephalopathy – Diagnostics Ehlers-Danlos syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Xylitol Hepatitis B Surface Antigen Misoprostol Interferon Beta-1B Pramipexole Tiragolumab Human Coagulation Factor Viii Tigulixostat Teicoplanin Gadoquatrane Ceftazidime Ulotaront Sarilumab Bifikafusp Alfa Ustekinumab Daunorubicin Hydrochloride CAMOSTAT MESILATE Ioversol Lazertinib Tusamitamab Ravtansine More therapies…

    Learn about Your Condition

    Abdominal infection Abdominal wall pain Alcohol use disorder Hepatitis B Apheresis Hairy cell leukaemia Epiphysiolysis Post procedural hypotension Lipid metabolism disorder Fibrosarcoma Langerhans' cell histiocytosis Nicotine dependence Wolfram syndrome Tardive dyskinesia Acarodermatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Phase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Linvoseltamab
    France Germany Greece Italy Norway Poland +1

  • Treatment of Post‑Traumatic Stress Disorder with inhaled nitrous oxide, oxygen, and nitrogen in adults: a multicenter randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Nitrogen
    • Nitrous Oxide
    • Oxygen
    France

  • Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo

    Not yet recruiting

    3 1
    Investigated Drugs:
    • LY3537031
    Germany Greece Poland Spain

  • Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

    Not yet recruiting

    2 1
    Denmark Germany The Netherlands Spain

  • Ticagrelor monotherapy vs ticagrelor plus acetylsalicylic acid in patients with myocardial infarction treated medically

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial infarction
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Ticagrelor
    France

  • Safety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Coronary artery disease
    Sweden
Previous Page
1 … 659 660 661 662 663 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!